Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASV and DCV immune-status study in chronic hepatitis C
NL-OMON40207Active, not recruiting
- Sponsor
- Stichting Maag-, Darm- en Leveronderzoek
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of asunaprevir and daclatasvir in hepatitis C virus infection, sponsored by Stichting Maag-, Darm- en Leveronderzoek. Primary endpoints: Immune-cell functionality in blood before, during, and after ASV and DCV therapy, Effect of viral load reduction on immune status and 1 more. Started Mar 2014; status: active, not recruiting.
02
Drugs
asunaprevirdaclatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON40207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40207.